Treace Medical Concepts, Inc. (TMCI) CEO John Treace on Q1 2022 Results - Earnings Call Transcript

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET

Company Participants

Vivian Cervantes - Investor Relations
John Treace - Chief Executive Officer
Mark Hair - Chief Financial Officer

Conference Call Participants

Drew Ranieri - Morgan Stanley
Danielle Antalffy - SVB Securities

Operator

Good day and thank you for standing by. Welcome to the Treace Medical Concepts’ First Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Vivian Cervantes, Gilmartin Group Investor Relations. Please go ahead.

Vivian Cervantes

Thank you, Kim. Good afternoon, everyone and welcome to our first quarter 2022 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer and Mark Hair, Chief Financial Officer.

During the call, we will offer commentary on our commercial activity and review our first quarter financial results released after the close of the market today, after which we will host a question-and-answer session. The press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will be archived in the Investors section of our website.

Before we begin, we would like to remind you that it is our intent that all forward-looking statements made during this call will be protected under the Private Securities Litigation Reform Act of 1995. Any statements that relate to expectations or predictions of future events and market trends as well as our estimated results or performance are forward-looking statements. All forward-looking statements are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. All forward-looking statements are based upon current available information, and Treace assumes no obligation